candesartan and Glomerulonephritis, Membranous
candesartan has been researched along with Glomerulonephritis, Membranous in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kamei, K | 1 |
Nakagawa, A | 1 |
Otsuka, Y | 1 |
Nakayama, M | 1 |
Kobayashi, S | 1 |
Matsuoka, K | 1 |
Iijima, K | 1 |
Mogensen, CE | 1 |
Other Studies
2 other studies available for candesartan and Glomerulonephritis, Membranous
Article | Year |
---|---|
Chronic glomerulonephritis associated with IgG subclass deficiency.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Benzimidazoles | 2007 |
Diabetic nephropathy: evidence for renoprotection and practice.
Topics: Adrenergic beta-Antagonists; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting E | 2000 |